The molecular characterization of LS patients relies on the identification of point mutations and large rearrangements in the coding regions of the MMR genes, MLH1, MSH2, PMS2, and MSH6 [8,9,10,11,12,13]. Here, MSH2 is linked to Leigh syndrome.